‘GLP-1 Supreme’, ‘Support’ and GLP-1 drops: what’s in them and why they aren’t medicines
Pills and drops sold as ‘GLP-1’ are food supplements, not medicines. Here’s what they contain, what the studies and EU law say, why there’s no such thing as Wegovy drops, and how to spot an illegal sale.

Short answer
Products sold as ‘GLP-1 Supreme’, ‘GLP-1 Support’ or GLP-1 drops are food supplements, not medicines. They usually contain berberine, chromium, fibre or probiotics and don’t reproduce the effect of semaglutide. No health claim about GLP-1 or satiety is authorised in the EU, and Wegovy drops or liquid don’t exist in Spain: it is only available as tablets and pens, on prescription and from a pharmacy.
Key points
- EU Regulation 432/2012 includes no health claim about GLP-1, satiety or berberine; the closest is the glucomannan claim, which contributes to weight loss only as part of an energy-restricted diet.
- Berberine reduces weight by an average of 0.88 kg compared with control, according to a meta-analysis of 23 trials published in 2026 in the International Journal of Obesity.
- A draft EFSA opinion dated 22/04/2026, not yet final, concludes that a safe intake of berberine-containing preparations can’t be established from the available data.
- CIMA, the AEMPS register, lists 38 semaglutide presentations, all from Novo Nordisk and only as pens or tablets: there are no drops and no generics in Spain.
- On 02/09/2026 the AEMPS withdrew 22 slimming products presented as natural that contained sibutramina, a drug not authorised in the EU.
Common ingredients in ‘GLP-1’ supplements: what the law and the studies say
What the law allows each ingredient to claim, and what has actually been measured, don’t match what the adverts promise: none of them has an authorised claim about GLP-1.
| Ingredient | Claim authorised in the EU | Measured effect on weight | Safety warning |
|---|---|---|---|
| Berberine | None | −0.88 kg on average (meta-analysis of 23 trials) | Draft EFSA opinion: no safe intake established; may inhibit CYP3A4. The OCU advises against it |
| Glucomannan | Contributes to weight loss, only with an energy-restricted diet (3 g a day) | No figure in the sources for this article | Mandatory warning about the risk of choking |
| Chromium | Maintenance of normal blood glucose levels (not weight) | No figure in the sources for this article | No specific warning in the sources for this article |
| Pasteurised Akkermansia muciniphila | None (it is an authorised novel food) | No figure in the sources for this article | Authorised for use up to 3.4 × 10^10 cells a day |
| Probiotics | None on weight | Depends on the strain | No specific warning in the sources for this article |
Products sold as ‘GLP-1 Supreme’, ‘GLP-1 Support’ or GLP-1 drops are marketed as food supplements, not medicines. They don’t reproduce the effect of semaglutide, and no health claim about GLP-1 or satiety is authorised in the European Union. They usually contain ingredients such as berberine, chromium, fibre or probiotics, which have small effects on weight. There is also no such thing as Wegovy drops or liquid Wegovy: in Spain, semaglutide is only sold as tablets or pens, on prescription and from a pharmacy.
What are ‘GLP-1 Supreme’, ‘Support’ supplements and GLP-1 drops?
They are products that borrow the name of the most searched-for medicine of the moment. A review for pharmacists, published in Pharmacy Times in May 2026, describes these over-the-counter ‘GLP-1 boosters’. They are promoted in pharmacies, online and on social media as natural alternatives, and their usual ingredients are berberine, chromium picolinate, resveratrol, fibre, green tea extract and probiotics. The same review concludes that they don’t reproduce the receptor activation or the clinical results of the medicines.
Each brand combines these ingredients in its own way, and we haven’t analysed the label of any specific product here, so what follows applies to the category as a whole. The underlying difference is one of scale. The GLP-1 your gut produces lasts 2 to 3 minutes in the bloodstream, while semaglutide lasts about a week. We explain how the real medicines work in what GLP-1 drugs are and how they work.
What does EU law say about these supplements?
A food supplement can only claim the effects listed in the EU register of authorised health claims, Regulation 432/2012. That list contains no claim about GLP-1, satiety or berberine. The closest are two statements. The glucomannan claim says that, ‘in the context of an energy-restricted diet, it contributes to weight loss’. It comes with a condition of 3 g a day in three 1 g doses taken with water before meals, plus a mandatory warning about the risk of choking. The chromium claim says it contributes to the maintenance of normal blood glucose levels, which is not the same as losing weight. Claims for meal replacements as part of an energy-restricted diet are also authorised.
In Spain, Royal Decree 1907/1996 also bans advertising for products with supposed health purposes that suggest specific slimming or anti-obesity properties, that use the word ‘natural’ as if it had therapeutic effects, that claim to replace medicines, or that suggest you can do without a doctor. An advert presenting drops as a natural GLP-1 that replaces the injection breaks several of those rules at once.
Do berberine, chromium or fibre work for weight loss?
Berberine
This is the most studied ingredient and the one most often sold as ‘natural Ozempic’. The most recent meta-analysis, covering 23 randomised trials, found an average reduction of 0.88 kg compared with control, 0.48 BMI points and 1.32 cm off the waist, and its authors call for better trials. Earlier meta-analyses ranged from no significant effect to around 2 kg. To put that figure in context: in the OASIS 4 trial, oral semaglutide achieved an average weight loss of 13.6% over 64 weeks, compared with 2.2% on placebo.
Safety is a bigger concern than effectiveness. The Spanish consumer organisation OCU advises against it. It describes diarrhoea, abdominal pain, nausea, hypotension, bradycardia and hypoglycaemia, interactions with up to 17 medicines, and points out that berberine crosses the placenta and passes into breast milk. On 22 April 2026, the European Food Safety Authority (EFSA) presented a draft opinion, still under consultation and not a final decision. It points to signs of genotoxicity in the laboratory that haven’t been confirmed in living organisms, the lack of a proper repeated-dose toxicity study, and digestive discomfort in trials using 400 to 1,500 mg a day. It also notes that berberine can inhibit CYP3A4, an enzyme that clears many drugs from the body. Based on these data, the draft concludes that a safe intake can’t be established.
Chromium, glucomannan and fibre
Chromium has an authorised claim about blood glucose, not about weight. Glucomannan is the only fibre with a weight-loss claim, and only as part of an energy-restricted diet. Without that diet, the claim can’t be used.
Probiotics and Akkermansia
The effect of a probiotic depends on the strain, and the EU list contains no claims about probiotics and weight. Pasteurised Akkermansia muciniphila is authorised in the EU as a novel food for use in supplements, up to 3.4 × 10^10 cells a day. It is still a food, though, and has no authorised claim about GLP-1 or weight.
Do Wegovy drops or liquid Wegovy exist?
No. CIMA, the register of the Spanish Agency of Medicines and Medical Devices (AEMPS), lists 38 semaglutide presentations, all from Novo Nordisk: 28 solutions for injection in pre-filled pens and 10 tablets. There are no drops, syrups or oral solutions, and no generics either. In Spain, Wegovy is available as 1.5, 4, 9 and 25 mg tablets and as pens, always on prescription and not funded by the Spanish National Health System. The generics already available in Canada and India are injectable pens.
Copies are circulating outside pharmacies. In September 2025 the AEMPS, together with the European Medicines Agency (EMA), warned of a sharp rise in illegal medicines sold as GLP-1 drugs through fraudulent websites and social media. These may not contain the stated active ingredient and may contain harmful substances. In 2023 the EMA found falsified Ozempic pens at European wholesalers, and in February 2026 Trinidad and Tobago issued a warning about falsified Wegovy tablets. Meanwhile, by 31 May 2026 the US Food and Drug Administration had received 990 adverse event reports involving compounded semaglutide, which it neither approves nor reviews, and it warns about products sold as ‘for research use only’.
The problem isn’t limited to GLP-1 products. On 2 September 2026 the AEMPS withdrew 22 slimming products that contained sibutramina, a drug banned in the EU because of its cardiovascular risks, and seven of them also contained phenolphthalein. According to the agency, they were presented as natural and hid their real composition.
How can you spot an illegal sale?
- It sells semaglutide, Wegovy-style pills or pens online or without a prescription: in Spain the law bans distance selling of prescription-only medicines (article 3.5 of Royal Legislative Decree 1/2015).
- The website isn’t a pharmacy, or doesn’t show the EU common logo: only authorised pharmacies that have registered the activity can sell online, they can only sell non-prescription medicines, and the logo links to the health authority so you can check (Royal Decree 870/2013).
- It advertises a prescription medicine to the public, on social media or by message: that kind of advertising is banned in Spain (article 80 of the same law).
- It promises weight loss, or presents itself as ‘natural’ or as a substitute for the medicine or for seeing a doctor: that is exactly the advertising Royal Decree 1907/1996 prohibits.
- It offers Wegovy or semaglutide drops, syrup or ‘liquid’, or something labelled ‘for research use only’: in Spain, none of these exist as an authorised medicine.
If you’ve already bought something like this, the sensible thing is not to take it and to talk to your doctor or pharmacist. We explain how the legal route works, with a prescription and a pharmacy, in our guide to buying Ozempic and Mounjaro in Spain legally and safely, and what to expect from an online medical service in our guide to choosing an online weight-loss clinic: what to compare and what to ask for.
What we know about the foods and habits that boost your own GLP-1 is covered in natural GLP-1, and the medicines backed by evidence in prescription weight-loss pills.
What are the alternatives if you really need to lose weight?
The key takeaway: a supplement with the medicine’s name on the label doesn’t contain it or mimic it. Anything sold as the medicine outside a pharmacy is illegal and may be fake.
If you need to lose weight with a doctor behind you, AiON offers medical weight-loss treatment with an initial assessment, a prescription from a registered doctor where appropriate, and ongoing follow-up. You can:
Sources
- Reglamento (UE) n.º 432/2012, lista de declaraciones de propiedades saludables autorizadas (anexo)
- Elahi Vahed I et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes 2026
- EFSA's draft opinion on the safety of plant preparation containing berberine (22/04/2026)
- CIMA AEMPS, medicamentos con semaglutida
- AEMPS: la EMA y HMA advierten del aumento de medicamentos ilegales comercializados como análogos de GLP-1
- BOE, Real Decreto 1907/1996, publicidad de productos con pretendida finalidad sanitaria
It's time to reach your goal.
Online medical assessment, prescription when appropriate and 1:1 follow-up with this team.
Frequently asked questions
- Can I buy Wegovy tablets without a prescription in Spain?
No. Wegovy tablets are a prescription-only medicine and can only be dispensed by a pharmacy with a prescription. The law also bans selling prescription medicines online, so any website offering them without a prescription is selling them illegally.
- Can I take berberine if I’m on other medication?
That’s exactly where the risk lies. The OCU describes interactions with up to 17 medicines, including digoxin, statins and metformin, and the draft EFSA opinion notes that berberine can inhibit CYP3A4, an enzyme that clears many drugs from the body. If you take any medication, the decision is for your doctor or pharmacist.
- Is any supplement approved for weight loss in Europe?
None is approved as a treatment, but some ingredients have an authorised claim. Glucomannan can state that it contributes to weight loss as part of an energy-restricted diet, and meal replacements can state that replacing meals in an energy-restricted diet helps with losing weight or keeping it off. There are no authorised claims about GLP-1 or satiety.
- Are there cheaper generic versions of semaglutide?
Not in Spain: every semaglutide presentation in CIMA comes from Novo Nordisk. The generics already sold in Canada and India are injectable pens authorised there, not pills or drops.
Keep reading
Vitamin D: what the evidence does (and doesn't) say about supplementing
Vitamin D is probably the most widely taken and least well understood supplement of all. We look at what the large randomised trials show on cancer, heart disease, fractures and respiratory infections, what levels are actually measured in Spain, and why the AEMPS has had to warn about poisoning from overdosing.
ReadNutraceuticals and supplementsAshwagandha: what it is, what the evidence says and why several European countries have restricted it
Ashwagandha is the star plant on the supplement shelves: it promises calm, less stress and better sleep. The evidence shows a small effect on anxiety and cortisol, while several European agencies have raised red flags over the liver and the thyroid. Here is what is known, what is not, and where it stands from a regulatory point of view in Spain.
Read




